1. Home
  2. HRI vs DYN Comparison

HRI vs DYN Comparison

Compare HRI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Herc Holdings Inc.

HRI

Herc Holdings Inc.

N/A

Current Price

$165.16

Market Cap

4.7B

Sector

Industrials

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$25.88

Market Cap

4.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRI
DYN
Founded
1965
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Corporate Leasing Services
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.8B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
HRI
DYN
Price
$165.16
$25.88
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$162.33
$37.00
AVG Volume (30 Days)
464.7K
2.5M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,376,000,000.00
N/A
Revenue This Year
$10.12
N/A
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.65
N/A
52 Week Low
$88.45
$11.92
52 Week High
$188.35
$27.31

Technical Indicators

Market Signals
Indicator
HRI
DYN
Relative Strength Index (RSI) 54.27 58.62
Support Level $150.81 $16.45
Resistance Level $172.56 $26.96
Average True Range (ATR) 6.59 0.96
MACD -0.60 -0.14
Stochastic Oscillator 62.79 67.04

Price Performance

Historical Comparison
HRI
DYN

About HRI Herc Holdings Inc.

Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is also pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60%/40%).

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: